Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411456 | SCV000486111 | likely pathogenic | Ataxia-telangiectasia syndrome | 2016-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000411456 | SCV002232445 | pathogenic | Ataxia-telangiectasia syndrome | 2021-05-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with ATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 370725). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu581Ilefs*7) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). |
Baylor Genetics | RCV003470333 | SCV004205779 | likely pathogenic | Familial cancer of breast | 2023-10-31 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003470333 | SCV004933718 | pathogenic | Familial cancer of breast | 2024-01-16 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |